At a glance
The July 26, 2021, Clinical Laboratory COVID-19 Response (CLCR) call included updates on the SARS-CoV-2 variants and genomic changes, as well as an FDA update.
Agenda
Archived LOCS Materials Access
Welcome: Nancy Anderson, CDC Division of Laboratory Systems (DLS)
CDC Influenza SARS-CoV-2 Multiplex Assay: Brandi Limbago, CDC Laboratory and Testing Task Force for the COVID-19 Response
Genomic Changes Causing SARS-CoV-2 Detection Partial Failure: Daniel D. Rhoads, Cleveland Clinic
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.